Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals...

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• Immune dysregulation involving FOXP3+ regulatory T cells (Tregs) and effector T cells contributes to type 1 diabetes (T1D) and loss of self-tolerance.
• Interleukin-2 (IL-2) signaling is crucial for Treg generation and function; its impairment is implicated in T1D pathogenesis.
• Polymorphisms in IL-2 pathway genes and reduced IL-2 signaling in some T1D patients suggest a role for this pathway in Treg dysfunction.

Purpose of the Study:

• To investigate the impact of reduced IL-2 sensitivity on Treg frequency and function in individuals with type 1 diabetes.
• To explore the relationship between IL-2 responsiveness, Treg stability, and suppressor capacity in T1D patients.

Main Methods:

• Analysis of IL-2 sensitivity via STAT5a phosphorylation in CD4+ T-cell subsets from 70 individuals with long-standing T1D.
• Assessment of Treg frequency and FOXP3 expression under varying IL-2 concentrations.
• Evaluation of Treg suppressor function in relation to IL-2 signaling levels.

Main Results:

• IL-2 responsiveness demonstrated stable intra-individual phenotype with significant inter-individual variation, influenced by T1D-associated PTPN2 gene polymorphisms.
• Individuals with lower IL-2 signaling exhibited reduced Treg frequency.
• Tregs from individuals with lower IL-2 signaling showed diminished ability to maintain FOXP3 expression and reduced suppressor function.

Conclusions:

• Reduced IL-2 signaling is associated with Treg dysfunction in type 1 diabetes.
• Lower IL-2 sensitivity correlates with decreased Treg frequency, impaired FOXP3 stability, and reduced suppressor capacity.
• Measuring IL-2 signaling may identify T1D patients with significant Treg dysfunction who could potentially benefit from IL-2 immunotherapy.